Lee Cooper Appointed President and CEO of GE Healthcare, United States and Canada

Published on:

WAUWATOSA, Wis., November 20, 2015 — GE Healthcare (NYSE: GE) today announced the appointment of Lee Cooper as president and CEO of GE Healthcare’s United States and Canada (USCAN) region, effective January 1, 2016. Cooper succeeds Marcelo Mosci, who is retiring from GE on April 1, 2016, after 16 years with the company.

Cooper, currently the vice president of global sales and marketing with GE Energy Management, is a 25-year GE veteran and a seasoned commercial leader. He brings a wealth of commercial experience to GE Healthcare and previously served as GE’s Chief Commercial Officer, where he was instrumental in driving commercial intensity by removing bureaucracy, improving processes, and enabling local decision-making.

“The healthcare markets in the United States and Canada are incredibly competitive,” John Flannery, president and CEO, GE Healthcare said. “We have selected a proven leader who will continue Marcelo’s legacy of being nimble and focused on innovating around our customers’ needs. In his 25 years at GE, Lee has been a champion for our customers. He will bring incredible value to this role and will continue to build on the success Marcelo has achieved over the last six years."

Cooper has also served as the Chief Commercial Officer of GE Capital Americas and led GE Capital’s sales efforts for their strategic customers. Cooper has a track record of continually connecting with commercial teams and customers to ensure the best outcomes for customers and GE.

About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.

Related Content

FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death
FDA issues Class I recall on insertion tubes after manufacturing error

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.